RCE - High Yield - Cardiac Genetics Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

VIP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

What are the skin and eye findings in patients with ACTA2 mutations?fcholester

A

Skin - Livedo reticularis

Eye - Iris flocculi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

VIP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

Prophylactic Surgical Repair of the Aorta; when is it done in the following scenarios?

  • Loeys-Dietz syndrome
  • Marfan syndrome (FBN1)
  • ACTA2 mutations
  • Pregnancy
A

Loeys-Dietz syndrome or TGFBR1 or TGFBR2 = 4 cm

ACTA2 mutations = When the aortic root or ascending aorta reaches a maximum diameter of 4.5 cm.

Marfan syndrome (FBN1) = The aortic root can be monitored to 5 cm unless there is a family history of dissection at smaller diameters (<5.0 cm), rapid enlargement (i.e. >0.5 cm per year), or significant aortic regurgitation.

Pregnancy = For women anticipating pregnancy, the threshold is anything that exceeds 4 cm: 4.1-4.5 cm.

___________________

Other notes:
When the specific cause of HTAD has not been identified, surgical repair is based on:
- The aortic diameter at the time of an aortic dissection in affected relatives.

Surgery is typically recommended when the diameter of the aorta is approximately twice normal - which depends on age, sex, and BSA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

VIP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

Multisystem smooth muscle dysfunction syndrome (ACTA2):

  • Inheritance?
  • Clinical features?
A

INHERITANCE:
Autosomal dominant

CLINICAL FEATURES:

CNS:

  • Early onset Moyamoya-like cerebrovascular disease with:
  • Dilatation of the proximal internal carotid artery
  • Stenosis/occlusion of the terminal internal carotid artery
  • Abnormally straight course of the intracranial arteries
  • Small vessels occlusion that cause bilateral periventricular white-matter hyperintensities observed on brain MRI
  • Ischemic stroke

EYES:

  • Congenital mydriasis (Dilatation of the pupil)
  • Small vessel retinal infarcts, tortuosity, and aneurysms

CARDIOVASCULAR:

  • Early onset thoracic aortic aneurysm - typically fusiform and initially involve the aortic root, extending into the ascending aorta and aortic arch
  • Aortic coarctation
  • Large patent ductus arteriosus (PDA)
  • Pulmonary artery hypertension
  • Early onset coronary artery disease

GASTROINTESTINAL:
- Hypoperistalsis of the gut and malrotation

GENITOURINARY:
- Hypotonic bladder
(associated with dilated ureters, calyces and or renal pelves, hydronephrosis, vesicoureteral reflux and recurrent urinary tract infections)
- Prune belly sequence

EXTREMITIES:
- Brachial artery occlusion with limb ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

VIP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

Photo slides

A

See PowerPoint - High Yield Photos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

VIP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

Genotype phenotype correlation in patients with ACTA2 mutations?

A

Pathogenic variants that alter the Arg.179 residue cause:

  • Multisystemic smooth muscle dysfunction syndrome
  • Cerebrovascular disease (early onset Moyamoya-like cerebrovascular disease)

The pathogenic variant p.Arg149Cys is associated with iris flocculi.

The pathogenic variants p.Arg118Gln and p.Arg149Cys are associated with early onset coronary artery disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

IMP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

When evaluating for a thoracic aortic aneurysm, the aortic diameter is measured using which imaging modalities?

A

Transthoracic Echocardiography: is used to detect aortic root dilation

CT or MRI: can be used to detect dilation above the aortic root if echocardiography cannot properly evaluate these locations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

IMP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

What are the causes of Heritable Thoracic Aortic Disease (HTAD)?

A

Marfan syndrome (FBN1)

Vascular Ehlers-Danlos syndrome (COL3A1)

Loeys-Dietz syndrome (TGFBR1, TGFBR2, TGFB2, TGFB3, SMAD3)

Multisystem smooth muscle dysfunction syndrome and nonsyndromic HTAD heritable thoracic aortic disease (ACTA2)

FOXE3

LOX (also associated with bicuspid aortic valve, abdominal aortic aneurysm, hepatic artery aneurysm)

MYH11 (also associated with patent ductus arteriosus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IMP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

What is the advised surveillance for thoracic aortic disease in the:

  • Proband
  • First-degree relatives
A

PROBAND and FIRST DEGREE RELATIVES WHO TEST POSITIVE:

After diagnosis of aortic dilatation, aortic imaging should be repeated in six months to assess the rate of aortic growth:

  • If it remains stable - yearly imaging.
  • If the rate of growth > 0.5 cm per year or if the ascending aorta and/or the aortic root exceeds about 4.0 cm in diameter - more frequent imaging should be considered

FIRST-DEGREE RELATIVE - NO GENE IDENTIFIED:
If the proband has:
- An aortic root aneurysm, screen by echocardiography
- An ascending aortic aneurysm, screen by CT or MRI (if echocardiography cannot visualize the aortic root adequately).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

IMP - Familial Thoracic Aortic Aneurysms Leading to Acute Aortic Dissections

What is the advised medical treatment?

A

Medical therapy should be started once the aorta is dilated or in individuals with a known pathogenic variant in an HTAD-related gene and no enlargement of the aorta.

  1. Medications include:
    - Beta adrenergic-blocking agents - e.g. atenolol
    - Angiotensin II receptor blocker (ARB) - e.g. Losartan (has shown efficacy in Marfan syndrome)
  2. Hypertension should be aggressively treated and controlled.
  3. Other cardiovascular risk factors, including smoking and hyperlipidemia, should be addressed.
  4. Avoidance of isometric exercises and contact sports is recommended.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

VIP - Long QT syndromes

What is the trigger for long-QT syndrome in individuals with variants in the following genes?

KCNQ1
KCNH2
SCN5A

NB: Of the 15 genes known to be associated with LQTS, these are the most common, in this order.

A

KCNQ1 = LQTS1 (AD; potassium channel)

  • Exercise (jumping into cold water, swimming, running, competitive sports)
  • Emotion (anger, crying, test taking, or other stressful situations, amusement park rides, frightening movies)

KCNH2 = LQTS2 (AD; potassium channel)

  • Exercise
  • Emotion (anger, crying, test taking, or other stressful situations)
  • Auditory stimuli (startling, alarm clock, loud horn, ringing phone)
  • Sleep

SCN5A = LQTS3 if GOF (Brugada if LOF) - (AD; sodium channel)

  • Sodium channel blocking medications
  • High fever
  • Sleep

MNEMONIC:

  • Q1 = That’s me - I get palpitations with exercise, anxiety
  • H2 = That’s Heba - include startled and sleep
  • S for sodium; sleep; sweaty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

VIP - Long QT syndromes

What medication is the first line management?

What is important to note?

A

MEDICATION:
- B-blockers (Nadolol - longer acting)

NB:
- All asymptomatic individuals meeting diagnostic criteria for LQTS, including those who have a pathogenic variant on molecular testing and a normal QTc interval - should be started on medication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

VIP - Long QT syndromes

What advice/recommendations should you give to the patient with a diagnosis of LQTS?

A

GENERAL ADVICE

  1. Avoid triggers such as:
    - Vigorous exercise, competitive sports / activities associated with intense physical activity and/or emotional stress
    - Exposure to loud noises such as alarm clocks and phone ringing
  2. Avoid medications that cause further prolongation of the QT interval or provoke torsade de pointes, such as:
    - Mood stabilizers (Lithium)
    - Antibiotics (Fluoroquinolones)
    - Tricyclic antidepressants (Amitriptyline)
    - Antipsychotics (Quetiapine)
  3. Consider implantable cardioverter-defibrillators (ICD) for those with:
    - Beta-blocker-resistant symptoms
    - Inability to take beta blockers
    - History of cardiac arrest
    - Asymptomatic but suspected to be at very high risk (e.g., those with ≥2 pathogenic variants on molecular testing)
  4. Testing of presymptomatic at-risk family members (especially of individuals age <18 years, as the risk for cardiac events is greatest in childhood):
    - To prevent syncope and sudden death.
  5. Consider availability of automatic external defibrillators at home, at school, and in play areas
  6. Importance of follow up for surveillance and ensuring compliance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

VIP - Long QT syndromes

A pregnant woman, previously shown to be a carrier of a pathogenic KCNH2 variant with normal ECG’s for the past 10 years is on a B-blocker.

The variant has recently been reclassified as a VUS, and so the patient wants to stop the medication.

What is your advice for follow up and management?

A

INQUIRE:
1. What lead to her investigation for LQTS in the first place? Was she symptomatic? Is there a family history?

  1. Who else in the family has been tested for this variant? Are they symptomatic?

POSSIBILITIES:
1. If a clinical diagnosis was made in the family, and she was just tested for the familial variant, it is possible that she is still at risk, but the underlying molecular cause has not yet been identified.

IMPORTANT POINTS TO EMPHASIZE:
1. LQTS exhibits both inter- and intrafamilial VARIABILITY as well as REDUCED PENETRANCE of the ECG changes and symptoms; i.e. individuals with a pathogenic variant may have a normal QTc (defined as <440 msec) on baseline ECG and remain asymptomatic.

  1. Age-related risk in individuals with pathogenic variants: Cardiac events may occur from infancy through middle age but are most common from the preteen years through the 20s; cardiac events are uncommon after age 40 years, but females remain at risk after age 40 years.
  2. Whether the variant is clinically significant or insignificant, it may be transmitted in a clinically significant fashion to future generations as either autosomal dominant LQTS (i.e., Romano-Ward syndrome) or JLNS, a confusing phenomenon during pedigree evaluation.
  3. Regarding pregnancy, the postpartum period is associated with increased risk for a cardiac event, especially in individuals with the LQTS type 2 phenotype. Beta blocker treatment was associated with a reduction of events in this nine-month time period after delivery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

VIP - Long QT syndromes

Important points to ask on history.

A

Personal or family history of:

  • A confirmed clinical/molecular diagnosis of LQTS
  • Symptoms of tachyarrhythmias (torsades de pointes), like palpitations, dizziness, nausea
  • Syncope with or without stress in the absence of warning (ruling out vasovagal and orthostatic forms of syncope), and in the absence of aura, incontinence, and postictal findings (ruling out seizures)
  • Aborted cardiac arrest
  • Any identifiable triggers precipitating the attacks, like exercise, emotion, stress, or if they occured during sleep
  • Unexplained sudden cardiac death at age <30 years (i.e. in a child or young adult) or SIDS, in an immediate family member.

Rule out other factors that can lengthen the QTc interval:

  • QT-prolonging drugs
  • Electrolyte imbalance (like hypokalemia) secondary to diarrhea, vomiting, metabolic conditions, and unbalanced diets for weight loss (malnutrition or liquid protein diet).
  • Neurological conditions (subarachnoid bleed)
  • Primary myocardial problems: cardiomyopathy (HCM, DCM), myocarditis, ischemia

Review of systems inquiring about features that may be associated with syndromic LQTS:

  • Hearing loss
  • Dysmorphic features
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

VIP - Long QT syndromes

Important findings on physical exam and investigations.

A

PHYSICAL EXAM:
Features that may be associated with syndromic LQTS:
- Hearing loss
- Dysmorphic features

INVESTIGATIONS - ECG:
1. QTc prolongation (>470 msec in males; >480 msec in females), torsade de pointes

  1. During exercise:
    - Failure of the QTc to shorten normally
    - Prolongation of the QTc interval
    - Characteristic T-wave abnormalities
  2. QTc interval measurement during change from supine to standing position (prolonged)

CONFIRMS THE DIAGNOSIS:
The presence of a corrected QT interval ≥500 ms in repeated ECGs in the absence of a secondary cause for QT prolongation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

VIP - Long QT syndromes

Jervell and Lange-Nielsen syndrome

  • Classic presentation
  • Triggers
  • Gene
  • Inheritance
  • Treatment
  • Important counseling points
A

CLASSIC PRESENTATION:

  • Deafness: congenital profound bilateral sensorineural hearing loss
  • Prolongation of the QTc interval (usually >500 msec) is associated with: tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation
  • Syncopal episodes during periods of stress, exercise, or fright
  • Sudden death (more than half of untreated children with JLNS die before age 15 years)
  • Extra: Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS (> in KCNQ1)

TRIGGERS:

  • Intense or sudden emotion (anger, crying, test taking, or other stressful situations, amusement park rides, frightening movies)
  • Exercise (jumping into cold water, swimming, running, competitive sports)

GENES:
- KCNQ1 or KCNE1.

INHERITANCE:

  • Autosomal recessive: caused by biallelic pathogenic variants in either gene.
  • The milder presentation of JLNS associated with KCNE1 pathogenic variants compared to JLNS associated with KCNQ1 pathogenic variants.

TREATMENT:

  • Cochlear implantation to treat hearing loss
  • Beta-adrenergic blockers for long QT interval (only partially effective.);
  • Implantable cardioverter defibrillators (ICDs) for those with a history of cardiac arrest and/or failure to respond to other treatments;
  • Ensure availability of automated external defibrillators where appropriate;
  • Family members of individuals with JLNS should be trained in cardiopulmonary resuscitation (CPR) as up to 95% of individuals with JLNS have a cardiac event before adulthood;
  • Standard treatment for those with iron-deficiency anemia.

IMPORTANT COUNSELING POINTS:
- Parents and other heterozygous carriers will not have SNHL, but may or may not have the long QT syndrome (LQTS) phenotype associated with fainting and death heritable in an autosomal dominant manner. This form of LQTS is called Romano-Ward syndrome (RWS).

  • At conception, each sib of an affected individual has a: 25% chance of being affected with JLNS
    50% chance of being a carrier of a JLNS-causing pathogenic variant and potentially at risk for LQTS,
    25% chance of being unaffected and not a carrier.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

VIP - Long QT syndromes

Romano–Ward syndrome

  • Classic presentation
  • Gene
  • Inheritance
  • Triggers
A

CLASSIC PRESENTATION:
- The term “Romano-Ward syndrome” (RWS) refers to forms of long QT syndrome with a purely cardiac electrophysiologic disorder, inherited in an autosomal dominant manner (LQTS types 1-3, type 5, type 6, and types 9-15).
- Characterized by:
QT prolongation
T-wave abnormalities
Ventricular tachycardia torsade de pointes (TdP)

GENES:

  • Many: KCNQ1, KCNH2, and SCN5A are the most common
  • Only KCNQ1 and KCNE1 have been implicated in both RWS and JLNS.

INHERITANCE:
- Autosomal dominant

TRIGGERS:
- Noted previously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IMP - Long QT syndromes

Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia - give examples

A

Andersen-Tawil syndrome (LQTS type 7 - KCNJ2 - AD) is associated with prolonged QT interval, muscle weakness, and facial dysmorphism.

Timothy syndrome (LQTS type 8 - CACNA1C - AD) is characterized by prolonged QT interval and hand/foot, facial, and neurodevelopmental features.

Jervell and Lange-Nielson syndrome (JLNS), an LQTS disorder associated with biallelic pathogenic KCNQ1 or KCNE1 variants, is associated with profound sensorineural hearing loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

VIP - Long QT syndromes

OSCE scenario: VUS in one gene and pathogenic variant in another gene.

A

LQTS associated with biallelic pathogenic variants or heterozygosity for pathogenic variants in two different genes (i.e., digenic pathogenic variants) is generally associated with a more severe phenotype with longer QTc interval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

IMP - Long QT syndromes

Genotype-phenotype correlation = KCNH2

  • Genotype
  • Phenotype
  • Average QTc
  • ST-T-Wave Morphology
  • Incidence of Cardiac Events
  • Cardiac Event Trigger
  • Sudden Death Risk
A
  • Genotype: LOF - potassium channel gene
  • Phenotype: LQTS type 2
  • Average QTc: 480 msec
  • ST-T-Wave Morphology: Bifid T-waves
  • Incidence of Cardiac Events: 46%
  • Cardiac Event Trigger: Exercise, Emotion (anger, crying, test taking, or other stressful situations), Auditory stimuli (startling, alarm clock, loud horn, ringing phone), Sleep
  • Sudden Death Risk: 6%-8%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

IMP - Long QT syndromes

Genotype-phenotype correlation = KCNQ1

  • Genotype
  • Phenotype
  • Average QTc
  • ST-T-Wave Morphology
  • Incidence of Cardiac Events
  • Cardiac Event Trigger
  • Sudden Death Risk
A
  • Genotype: LOF - potassium channel gene
  • Phenotype: LQTS type 1
  • Average QTc: 480 msec
  • ST-T-Wave Morphology: Broad-base T-wave
  • Incidence of Cardiac Events: 63%
  • Cardiac Event Trigger: Exercise (jumping into cold water, swimming, running, competitive sports), Emotion (anger, crying, test taking, or other stressful situations, amusement park rides, frightening movies)
  • Sudden Death Risk: 6%-8%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

IMP - Long QT syndromes

Genotype-phenotype correlation = SCN5A

  • Genotype
  • Phenotype
  • Average QTc
  • ST-T-Wave Morphology
  • Incidence of Cardiac Events
  • Cardiac Event Trigger
  • Sudden Death Risk
A
  • Genotype: GOF - sodium channel gene
  • Phenotype: LQTS type 3
  • Average QTc: ~490 msec
  • ST-T-Wave Morphology: Long ST, small T
  • Incidence of Cardiac Events: 18%
  • Cardiac Event Trigger: Sodium channel blocking medications, High fever, Sleep
  • Sudden Death Risk: 6%-8%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

IMP - Long QT syndromes

What is the normal QTc value?

A

350 and 440 ms

24
Q

IMP - Brugada syndrome

  • Classic presentation
  • Triggers
  • Gene
  • Inheritance
  • Treatment
  • Important counseling points
A

CLASSIC PRESENTATION:
Presents primarily during adulthood although age at diagnosis may range from infancy to late adulthood.

  1. Sudden Unexpected Nocturnal Death Syndrome:
    - Sudden unexpected nocturnal death syndrome (SUNDS)
    - Sudden infant death syndrome (SIDS)
  2. Conduction defects:
    - First-degree AV block,
    - Intraventricular conduction delay,
    - Right bundle branch block,
    - Sick sinus syndrome

GENES:

  • Diagnosis is based on clinical findings and/or by the identification of a heterozygous (or hemizygous in the case of KCNE5 in a male) pathogenic variant in one of 23 genes: ABCC9, CACNA1C, CACNA2D1, CACNB2, FGF12, GPD1L, HCN4, KCND2, KCND3, KCNE5, KCNE3, KCNH2, KCNJ8, PKP2, RANGRF, SCN1B, SCN2B, SCN3B, SCN10A, SEMA3A, SLMAP, and TRPM4.
  • LOF variant in SCN5A

INHERITANCE:
Autosomal dominant

TREATMENT:

  • Quinidine (1-2 g daily)
  • Implantable cardioverter defibrillator (ICD) in individuals with a history of syncope or cardiac arrest;
  • Isoproterenol for electrical storms
  • Treatment of asymptomatic individuals is controversial.
25
Q

IMP - Tangier disease

Photo slides

A

See PowerPoint - High Yield Photos

26
Q

VIP - Alagille syndrome

List the cardiac and skeletal findings.

A

CARDIAC:
Peripheral pulmonary artery stenosis

SKELETAL:
Butterfly vertebrae

27
Q

IMP - Alagille syndrome

Photo slides

A

See PowerPoint - High Yield Photos

28
Q

IMP - Alagille syndrome

Characteristic clinical features (n=8 systems)

A

Mild intellectual disability

Poor growth*

DYSMORPHIC FEATURES
Dysmorphic features with typical facies*: triangular-shaped face with a broad forehead and prominent pointed chin, deep-set eyes with moderate hypertelorism, long straight nose with a bulbous tip, small low-set or malformed ears

EYE - anterior chamber anomalies
Posterior embryotoxon*
(identified on slit-lamp; doesn’t affect visual acuity)
Axenfeld anomaly (iris strands)

HEART
Peripheral pulmonary artery stenosis* with or without tetralogy of Fallot

SKELETON
Butterfly-like vertebrae*
Hemivertebrae
Rib anomalies

LIVER
Paucity of the intrahepatic bile ducts on biopsy*
Chronic cholestasis* and pruritus
Jaundice with conjugated hyperbilirubinemia*
Hepatomegaly
Hypercholesterolemia

Structural and or functional renal abnormalities*: renal dysplasia, renal cysts - renal tubular acidosis, decreased creatinine clearance

29
Q

IMP - Alagille syndrome

Gene(s) and inheritance pattern.
Mechanism.
Pathway.

A

JAG1
NOTCH2 (less commonly)

AD - variable expressivity with clinical features ranging from subclinical to severe.

Haploinsufficiency - LOF variants.

Notch signaling pathway.

30
Q

IMP - Alagille syndrome

Diagnostic criteria.

A

Bile duct paucity + 3/5 of the major clinical features:

  1. Cholestasis
  2. Cardiac defect
  3. Skeletal abnormalities
  4. Ophthalmologic abnormalities
  5. Characteristic facial features
31
Q

IMP - Alagille syndrome

Specific treatments.

A

Choleretic agents (ursodeoxycholic acid),
Liver transplantation for end-stage liver disease
*Kasai procedure is not recommended

32
Q

IMP - Alagille syndrome

What should be taken into consideration for individuals with ALGS and additional abnormalities, including developmental delay, hearing loss, and autism?

A

A larger deletion of chromosome 20p12 encompassing the entire JAG1 gene as well as other genes in the region.

33
Q

VIP - Holt-Oram syndrome

List the cardiac and skeletal findings.

A

CARDIAC:
Ventricular septal defect (VSD)

SKELETAL:
Radial ray defects and thumb abnormalities - absent, hypoplastic, triphalangeal

34
Q

IMP - Holt-Oram syndrome

Characteristic clinical features (n= 3 systems)

A

Heart and hand syndrome = Cardiac and limb syndrome

UPPER LIMBS
(Unilateral – Bilateral/symmetric or asymmetric)
- Narrow shoulders
- Radial ray anomaly
- Phocomelia
- Triphalangeal thumb
- Hypoplastic thumb
- Absent thumb
- An abnormal carpal bone is present in allaffectedindividuals and may be the only evidence of disease

CARDIAC (STRUCTURAL)

  • VSD
  • ASD

CARDIAC (CONDUCTION)

  • Sinus bradycardia
  • First-degree atrioventricular (AV) block
  • May progress to complete heart block
  • *Patient will need annual ECG
35
Q

IMP - Holt-Oram syndrome

Are there other clinical features?

A

No.

Observations of such features in individuals with upper limb deformity and/or cardiac septation defects should cast doubts upon any provisional diagnosis of HOS and should prompt the clinician to consider alternate diagnoses:

Postaxial upper limb (ulnar ray),
Syndactyly involving digits other than the thumb,
Polydactyly,
Lower limb anomalies,
Craniofacial defects,
Pulmonary anomalies,
Genitourinary anomalies,
Gastrointestinal malformations,
Vertebral anomalies / anal malformations
Intellectual difficulties
Sensory deficits (ear malformations with or without hearing loss / eye findings)

36
Q

IMP - Holt-Oram syndrome

What teratogenic exposure(s) may have overlapping features with this syndrome?

A

Thalidomide

Valproate

37
Q

IMP - Holt-Oram syndrome

Gene(s) and inheritance pattern.
Mechanism.
Pathway.

A

TBX5
Autosomal dominant
Marked variability - At-risk individuals with a normal physical exam should have X-rays of the wrists, arms, hands to check for subtle changes of the thumb and carpal bones + echocardiogram and ECG.

LOF or dominant-negative interference with function.

TBX5 functions as a transcription factor that has an important role in both cardiogenesis and limb development.

38
Q

VIP - Hypertrophic cardiomyopathy

List syndromes associated with hypertrophic cardiomyopathy (n=7)

A

Noonan syndrome
Cardiofaciocutaneous syndrome
Costello syndrome

Fabry disease
Pompe disease
VLCAD deficiency

Friedreich ataxia

MNEMONIC: The heavy ones

  • RASopathies - remember that dad
  • FPV: they all have build-up
  • FA: Nora’s brother - heavy hearted
39
Q

VIP - Hypertrophic cardiomyopathy

What are the pros and cons of panel testing?

A

PROS:

  • A multigene panel is comprehensive (i.e., comprising genes with established clinical validity, known to be associated with HCM). Furthermore, custom gene panels may be designed with the genes of interest.
  • A multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of uncertain significance and pathogenic variants in genes that do not explain the underlying phenotype.
  • Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non sequencing-based tests.

CONS:

  • The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and are likely to change over time.
  • Some multigene panels may include genes not associated with the condition of interest.
40
Q

IMP - Hypertrophic cardiomyopathy

Define hypertrophic cardiomyopathy.

A

Hypertrophic cardiomyopathy (HCM) is typically defined by the presence of unexplained left ventricular hypertrophy (LVH) with a maximum wall thickness ≥15 mm in adults or a z-score >3 in children.

41
Q

IMP - Hypertrophic cardiomyopathy

What are the acquired or secondary causes of LVH?

A

Pathologic, occurring in response to pressure overload:

  • Systemic hypertension
  • Aortic stenosis

Physiologic hypertrophy:
- Athlete’s heart may result from rigorous athletic training

HCM is infants of diabetic mothers - usually transient and benign.

42
Q

IMP - Hypertrophic cardiomyopathy

List 5 non-syndromic hypertrophic cardiomyopathy genes and the mode of inheritance for each. (n=5)

A

All are inherited in an AD manner.
Ordered starting with most common.

MYBPC3
MYH7
TNNI3
TNNT2
MYL2

*NB: LV tends to develop during childhood and adolescence.

MNEMONIC: 
Write: MY - MY - TNN - TNN - MY
BPC3 (BOPSY)
H7 (KNOWN)
I3 (TINY)
T2 (TINY TOO)
L2
43
Q

IMP - Hypertrophic cardiomyopathy

Who should be offered genetic testing for HCM?

A

The individual who best meets diagnostic criteria after obtaining a family history; ideally the most severely affected in the family.

44
Q

IMP - Hypertrophic cardiomyopathy

What are next steps if:

  • A pathogenic or likely pathogenic variant is detected?
  • A VUS or no variant is detected.
A

PATHOGENIC OR LIKELY PATHOGENIC:

  • Test at-risk family members
  • For those who test positive, arrange for clinical cardiac evaluations at recommended intervals

VUS:

  • Segregation study of selected family members
  • If remains uncertain, arrange for clinical cardiac evaluations at recommended intervals (for at-risk individuals)

NEGATIVE GENETIC TESTING RESULT:

  • The causative variant may be in a novel gene
  • Arrange for clinical cardiac evaluations at recommended intervals (for at-risk individuals)
  • Repeat testing when multigene panels are expanded to include more genes and test sensitivity increases (e.g., resulting from better coverage of the genes included and improved detection of deletions/duplications)
45
Q

IMP - Hypertrophic cardiomyopathy

Can a VUS be used for predictive testing?

A

No.

46
Q

IMP - Hypertrophic cardiomyopathy

What are the screening recommendations for family members of an affected individual who has a known pathogenic variant in an HCM-related gene - who test positive.

A

Baseline PE, ECG, and echo
Repeat ECG and echo every 1 - 2 yrs in children and adolescents
Repeat ECG and echo every 3 - 5 yrs in adults

47
Q

IMP - Hypertrophic cardiomyopathy

What are the screening recommendations for family members of an affected individual in whom the specific genetic cause of HCM has not been identified?

A

In all asymptomatic first-degree relatives (adults and children) of an individual with HCM in whom a pathogenic variant has not been identified:

  1. In adults, baseline PE, ECG, and echo and repeat ECG and echo every 3 - 5 yrs in adults.
  2. If the proband showed early onset (i.e., onset in infancy &/or childhood): Repeat ECG and echo every 1 - 2 yrs in children and adolescents starting at the time HCM is diagnosed in the proband.
  3. If the proband showed onset during or after puberty: Repeat ECG and echo every 2 - 3 yrs in children and adolescents starting at the time HCM is diagnosed in the proband, but no later than puberty.
48
Q

IMP - Dilated cardiomyopathy

Define dilated cardiomyopathy.

A

The diagnosis of DCM is established when both of the following are present:

  • Left ventricular enlargement
  • Systolic dysfunction with an EF <50%
49
Q

IMP - Dilated cardiomyopathy

Age of onset.

A

DCM usually initially manifests in adults in the fourth to sixth decade, although it may present at any age (prenatally; in infancy, early or late childhood, adolescence; or in the elderly).

50
Q

IMP - Dilated cardiomyopathy

List 5 causes of acquired or secondary DCM.

A
Ischemic injury (e.g. prior myocardial infarction) - most common
Valvular heart disease
Toxins (e.g. chemotherapeutic agents)
Thyroid disease, 
Inflammatory or infectious conditions, 
Severe long-standing hypertension, 
Radiation
51
Q

IMP - Dilated cardiomyopathy

List 5 syndromic causes of DCM.

A
Barth syndrome
Duchenne and Becker muscular dystrophy
Limb girdle muscular dystrophy 1B
HFE-associated hereditary hemochromatosis
Mitochondrial DCM

MNEMONIC:
Dilated = loose = dystrophy or damage to muscle
Barth and the guys + HFE tags along
Mito is the powerhouse of the cell; muscles are nothing without it

NB: For Barth syndrome
Gene: TAZ
Inheritance: XL

Features:	
Neutropenia
Muscle weakness
Growth delay
Infantile/early-childhood onset
52
Q

IMP - Dilated cardiomyopathy

List 5 non-syndromic dilated cardiomyopathy genes and the mode of inheritance for each. (n=5)

A
All are inherited in an autosomal dominant manner:
ACTC1	
ACTN2	
BAG3	
CSRP3
DES
53
Q

IMP - Dilated cardiomyopathy

Who should be offered genetic testing for DCM?

A

Molecular genetic testing should be offered to every individual of any age with nonischemic DCM.

54
Q

IMP - Differential diagnosis for posterior embryotoxon.

A
Alagille syndrome
Axenfeld-Rieger syndrome 
22q11. 2 deletion syndrome 
PHACES syndrome
SHORT syndrome
55
Q

IMP - Cardiac Genetics

Quick read

A

Differentials for specialty genetics: 20 cardiac slides